Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.
Boudin L, Gonçalves A, Sfumato P, Sabatier R, Bertucci F, Tarpin C, Provansal M, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Extra JM, Viens P, Chabannon C.
Boudin L, et al. Among authors: sabatier r.
J Cancer. 2016 Oct 23;7(14):2077-2084. doi: 10.7150/jca.15797. eCollection 2016.
J Cancer. 2016.
PMID: 27877223
Free PMC article.